These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9732018)

  • 1. Thrombocytopenia associated with oral terbinafine.
    Grunwald MH
    Int J Dermatol; 1998 Aug; 37(8):634. PubMed ID: 9732018
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolated thrombocytopenia associated with oral terbinafine.
    Tsai HH; Lee WR; Hu CH
    Br J Dermatol; 2002 Sep; 147(3):627-8. PubMed ID: 12207625
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversible agranulocytosis associated with oral terbinafine in a pediatric patient.
    Aguilar C; Mueller KK
    J Am Acad Dermatol; 2001 Oct; 45(4):632-4. PubMed ID: 11568763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Terbinafine (Lamisil)].
    Breton MC
    Union Med Can; 1995 Nov; 124(3):20-5. PubMed ID: 8560634
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of dermatophyte onychomycosis with three pulses of terbinafine (500 mg day for a week).
    Takahata Y; Hiruma M; Shiraki Y; Tokuhisa Y; Sugita T; Muto M
    Mycoses; 2009 Jan; 52(1):72-6. PubMed ID: 18444971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Terbinafine-induced persistent agueusia: first reported case].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2000 Mar; 127(3):341. PubMed ID: 10804319
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple onychocryptosis following treatment of onychomycosis with oral terbinafine.
    Weaver TD; Jespersen DL
    Cutis; 2000 Sep; 66(3):211-2. PubMed ID: 11006857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis.
    Avner S; Nir N; Henri T
    J Dermatolog Treat; 2005; 16(5-6):327-30. PubMed ID: 16428154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onychomycosis treated with a short course of oral terbinafine.
    Galimberti R; Kowalczuk A; Flores V; Squiquera L
    Int J Dermatol; 1996 May; 35(5):374-5. PubMed ID: 8734666
    [No Abstract]   [Full Text] [Related]  

  • 10. [The modern approach to the treatment for onychomycosis of hands and feet in the outpatient setting].
    Gerasimchuk EV; Gerasimov VV; Molchanov BA
    Voen Med Zh; 2005 Nov; 326(11):44-5. PubMed ID: 16404907
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutropenia and pancytopenia associated with oral terbinafine.
    Kovacs MJ; Alshammari S; Guenther L; Bourcier M
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):806. PubMed ID: 7929931
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral antifungal agents for onychomycosis.
    Wilson NJ; White SI
    Lancet; 1998 May; 351(9114):1516. PubMed ID: 9605836
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral corticosteroids did not prevent AGEP due to terbinafine.
    Bajaj V; Simpson N
    Acta Derm Venereol; 2006; 86(5):448-9. PubMed ID: 16955194
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute generalized exanthematous pustulosis induced by terbinafine.
    Taberner R; Puig L; Gilaberte M; Alomar A
    Eur J Dermatol; 2003; 13(3):313-4. PubMed ID: 12805000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new oral antifungal agents for onychomycosis of the toenails.
    Gupta AK; Shear NH
    J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):1-13. PubMed ID: 10565624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serious adverse events reporting on systemic terbinafine: a Danish register-based study.
    Bangsgaard N; Saunte DM; Folkenberg M; Zachariae C
    Acta Derm Venereol; 2011 May; 91(3):358-9. PubMed ID: 21290086
    [No Abstract]   [Full Text] [Related]  

  • 18. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
    Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
    Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
    Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA
    J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy consisting of week pulses of oral terbinafine plus topical application of terbinafine cream in the treatment of onychomycosis.
    Sanmano B; Hiruma M; Mizoguchi M; Ogawa H
    J Dermatolog Treat; 2004 Jul; 15(4):245-51. PubMed ID: 15764040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.